Profile
AADI VRTX REGN ALNY SGEN ARGX
Company Name Aadi Bioscience, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $94.89M $117.98B $58.16B $43.28B $43.15B $34.40B
Employees 0.05K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO David J. Lennon Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
AADI VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
AADI VRTX REGN ALNY SGEN ARGX
Last Close $2.05 $463.27 $550 $324.69 $228.74 $572.71
High 52 $3.73 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $1.35 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -45.04 % -10.35 % -54.23 % -2.18 % 0 % -14.74 %
Price vs. 52 Week Low 51.85 % 16.8 % 13.89 % 44.58 % 0 % 24.23 %
Total Return
AADI VRTX REGN ALNY SGEN ARGX
1 Month Return 0 % 3.32 % 7.09 % 3.96 % 0 % 6.47 %
3 Month Return 0 % -5.28 % -2.34 % 38.43 % 0 % -3.94 %
6 Month Return -31.21 % 9.78 % -19.31 % 31.84 % 0 % -10.59 %
9 Month Return -2.84 % -4.08 % -44.48 % 9.72 % 0 % 1.36 %
YTD Return -35.02 % 15.04 % -22.79 % 37.98 % 0 % -6.88 %
1 Year Return 33.99 % -5.09 % -48.47 % 37.17 % 0 % 22.75 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AADI VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.32 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -35.31 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
AADI VRTX REGN ALNY SGEN ARGX
Asset Growth -46.9 % -0.87 % 36.55 %
Gross Profit Growth 6.56 % 10.25 % 77.08 %
Revenue Growth 6.69 % 11.66 % 78.6 %
Revenue 3 Year 759.12 % 45.6 % 275.84 %
Revenue 5 Year 247.81 % 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth 1.09 % -93.69 % 128.87 %
Net Income Growth 3.15 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 80.87 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 72.56 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -14739.26 % 33.84 % 938.02 %
Operating Income Growth 6.22 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 0.19 % -113.93 % 80.31 %
Operating 3 Year CFG 12.19 % -118.65 % 88.36 %
Operating 5 Year CFG 74.97 % -131.3 % -135.21 %
Operating 10 Year CFG -16973.01 % 12.43 % -64 %
EPS Growth 3.28 % -114.8 % 369.77 %
EPS Diluted Growth 3.28 % -114.97 % 347.67 %
Book Value Per Share -50.24 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -87.28 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -85.6 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 2363.4 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share -100 % - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -34.25 % 116.42 % 95.27 %
Free Cash Flow Growth 3.82 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
AADI VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM -46.06 % 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM 11.8 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM 26.18 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -28.49 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM -43.72 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM -227.41 % -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM - -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 11.09 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM 111100 % 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM 11.87 % 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -1.3 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -1.33 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 579.11 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -186.36 % -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.83 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM - -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -1.73 -93.78 19.26 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -1.5 -120.39 14.79 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -1.5 -120.39 14.79 -954.11 -93.1 -526.76
Income Statement (TTM)
AADI VRTX REGN ALNY SGEN ARGX
Revenue $0.03B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0.02B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 88.36% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.06B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -2.36 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
AADI VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.05B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.02B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.07B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
AADI VRTX REGN ALNY SGEN ARGX
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AAPG 39.6201
AARD Aardvark Therapeutics, Inc. Common Stock 11.96
ABCL AbCellera Biologics Inc. 3.9
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.63
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.48
ABPWW 0.0225
ABSI Absci Corporation 2.88
ABUS Arbutus Biopharma Corporation 3.14
ABVC ABVC BioPharma, Inc. 3.58
ABVX Abivax SA American Depositary Shares 10.34
ACAD ACADIA Pharmaceuticals Inc. 22.55
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.79
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.75
ACIU AC Immune SA 2.07
ACLX Arcellx, Inc. 70.95
ETFs With Exposure to AADI
Ticker ETF Name Weight Percentage Price
VWO Vanguard Emerging Markets Stock Index Fund 0.01 50.55
IWM iShares Russell 2000 ETF 0.00002 223.92
VTI Vanguard Total Stock Market Index Fund 0 309.26
XBI SPDR S&P Biotech ETF 0.05 88.12
VT Vanguard Total World Stock Index Fund 0 129.98
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 137.43
ACWF iShares MSCI Global Multifactor ETF 0.02786 32.7935
VXUS Vanguard Total Intl Stock Idx Fund 0 69.28
VSS Vanguard FTSE All-World ex-US Small Capital Index Fund 0.02 135.96
IWN iShares Russell 2000 Value ETF 0.00004 164.33
LABU Direxion Daily S&P Biotech Bull 3X Shares 0.01 67.14
IWO iShares Russell 2000 Growth ETF 0.00934 294.86
TLTE FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.0105 59.83
VXF Vanguard Extended Market Index Fund 0 198.64
HDG ProShares Hedge Replication ETF 0.000190685 50.12
UWM ProShares Ultra Russell2000 0.000380553 40.41
IWC iShares Micro-Cap ETF 0.00939 134.14
URTY ProShares UltraPro Russell2000 0.000180747 43.52
VTWV Vanguard Russell 2000 Value Index Fund 0 144.906
BTEC Principal Healthcare Innovators ETF 0.0272886 39.49
SBIO ALPS Medical Breakthroughs ETF 0.0009 33.51
VFLQ Vanguard U.S. Liquidity Factor ETF 0.09 99.7611
VTWO Vanguard Russell 2000 Index Fund 0 90.52
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 105.15
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 105.13
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 50.18
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 50.17
VBINX Vanguard Balanced Index Fund Investor Shares 0 50.18
RYLD Global X Russell 2000 Covered Call ETF 0 15.05
AVEM Avantis Emerging Markets Equity ETF 0.02 70.07
DFAU Dimensional US Core Equity Market ETF 0.000457 43.13
DFAT Dimensional U.S. Targeted Value ETF 0.0000039245 55.62
DFAS Dimensional U.S. Small Cap ETF 0.00009244 65.59
DFAC Dimensional U.S. Core Equity 2 ETF 0.00000202 36.54
VTSAX Vanguard Total Stock Market Index Fund 0 150.5
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 150.57
VITSX Vanguard Total Stock Market Index Fund 0 150.53
AVES Avantis Emerging Markets Value ETF 0.05 54.82
DFSU Dimensional US Sustainability Core 1 ETF 0.0009425 39.96
VFSAX Vanguard FTSE All-World ex-US Small-Cap Index Fund Admiral Shares 0.02 33.53
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000729842 106.49
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 150.58
VEMAX Vanguard Emerging Markets Stock Index Fund Admiral Shares 0.01 41.87
VTIAX Vanguard Total International Stock Index Fd Admiral 0 37.19
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00112634 36.38
VTWAX Vanguard Total World Stock Index Fund Admiral Shares 0 46.01
TYNE Direxion Nanotechnology ETF 0.453966 17.2638
AVSC Avantis U.S. Small Cap Equity ETF 0 53.71
GLOF iShares Trust - iShares Global Equity Factor ETF 0.02786 48.64
DCOR Dimensional ETF Trust 0.00000627 68.13
VEMPX Vanguard Extended Market Index InstlPlus 0 371.57
VEMRX Vanguard Emerging Mkts Stock Idx InsPlus 0.01 105.9
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 282.37
AVXC Avantis Emerging Markets ex-China Equity ETF 0.05 57.4319
VTWIX Vanguard Total World Stock Index I 0 265.23
RSSL Global X Funds 0 87.93
VTPSX Vanguard Total Intl Stock Idx InstlPls 0 148.76
Unlock